{"id":205301,"name":"DOTCHIN & ASSOCIATES ON BEHALF OF EMERGENT BIOSOLUTIONS","slug":"dotchin-associates-on-behalf-of-emergent-biosolutions","state":"MD","country":"United States of America","description":"Global life sciences company","totalSpending":0,"filings":9,"yearlySpending":[{"year":2020,"income":0},{"year":2021,"income":0}],"issues":[{"code":"DIS","display":"Disaster Planning/Emergencies"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HOM","display":"Homeland Security"},{"code":"DEF","display":"Defense"}],"firms":["NEXA STRATEGIES, LLC"],"lobbyists":["SUZY GLUCKSMAN"],"govEntities":[],"sampleDescriptions":["FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government.  National Defense Authorization Act\nCOVID 19 provisions","FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government.  National Defense Authorization Act\nCOVID 19 provisions","FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government.  National Defense Authorization Act\nCOVID 19 provisions","FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government.  National Defense Authorization Act\nCOVID 19 provisions"]}